07
Nov
2018
17:30
GMT
Webinar
Use of Intravascular Ultrasound (IVUS) in Ambiguous Angiograms
-
Views:
2533
-
Likes:
0
Overview
Intravascular ultrasound (IVUS) can resolve abnormalities within the coronary artery to a degree that is not possible with angiography alone. With an axial resolution of 70-200 μm and lateral resolution of 200-400 μm, IVUS can provide information on arterial wall and luminal composition that can change clinical management decisions. This webinar series describes scenarios of clinical uncertainty where the coronary angiogram has not provided enough information. It also gives examples of how IVUS can help to clarify decision-making in such cases.
Read supporting paper here
https://www.radcliffecardiology.com/articles/use-intravascular-ultrasound-ivus-ambiguous-angiograms
Faculty:
Robert Gerber
Andrew SP Sharp
This webinar is supported by
Educational Objectives
- The limitations of angiographic imaging
- The benefits of IVUS over angiography for procedural planning
- The diagnostic role that IVUS can play in interventional procedures
- The reassurance IVUS provides post stent implantation
Target Audience
- Interventional Cardiologists
- Interventional Fellows
- Registrars with an interest in interventional cardiology
Faculty Biographies
Robert Gerber
Dr Robert Gerber is a Consultant Cardiologist at Conquest Hospital and Eastbourne District General Hospital in East Sussex. Having completed his medical training at King's College London, he went on to complete the MB/PhD programme.
Dr Gerber is qualified in both General Internal Medicine and General Cardiology with a sub-speciality in Interventional Cardiology. He has also previously worked as an Interventional fellowship at San Raffaele and Columbus Hospitals in Milan, Italy.
Dr Robert Gerber is also highly involved in research and teaching, and he is module leader for the MSc in Cardiology at Brighton and Sussex University (BSUH). He is also a member of the British Hypertension Society (BHS), the British Cardiovascular Intervention Society (BCIS) and the European Association of Percutaneous Coronary Intervention (EAPCI).
Dr Gerber has published extensively in the field of interventional cardiology, and is also the ESHT Principal Investigator of several randomized clinical trials. A keen sportsman, Dr Gerber uses his cardiac and sports knowledge to run healthy heart screening programmes.
Dr Robert Gerber is on the Editorial Board of European Cardiology Review.
Andrew SP Sharp
Prof Andrew Sharp is a Consultant Cardiologist at the University Hospital of Wales, Cardiff, UK. Andrew qualified from Edinburgh Medical School in 1998. He was appointed as a Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011 and Honorary Associate Professor by the University of Exeter in 2018 before moving to the University Hospital of Wales in Cardiff in the summer of 2019.
Andrew conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training, completing the prestigious Milan-Imperial Interventional Cardiology Fellowship programme. Dr Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and his current research interests include device-based treatments for hypertension, pulmonary embolism, intracoronary imaging and coronary physiology.
Andrew's specialist interests include the pharmacological and interventional treatment of resistant hypertension (including renal denervation); intra-coronary physiology to assess the causes of chest pain; complex angioplasty and stenting of coronary artery disease and CT coronary angiography.
Dr Andrew Sharp is Deputy Editor (Development) of Interventional Cardiology: Reviews, Research, Resources (ICR3)